Oncolin Therapeutics, Inc. Announces It Has Entered into Negotiations with a Leading Institution to Commercially Develop a Cancer Technology

April 8, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

HOUSTON--(BUSINESS WIRE)--Oncolin Therapeutics, Inc., (OTCBB:OCOL) announces that it has entered into negotiations with one of the world’s leading cancer institutes to commercially develop a new cancer technology.

Twitter
LinkedIn
Facebook
Email
Print

Alliances